|
YARS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.765254609154E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08430042722318E-10 |
| Normal-vs-Stage2 |
7.600300E-03 |
| Normal-vs-Stage3 |
1.37169999803177E-08 |
| Normal-vs-Stage4 |
1.06319999471083E-08 |
| Stage1-vs-Stage2 |
1.594240E-01 |
| Stage1-vs-Stage3 |
3.447400E-01 |
| Stage1-vs-Stage4 |
9.048300E-04 |
| Stage2-vs-Stage3 |
8.910000E-02 |
| Stage2-vs-Stage4 |
2.767500E-04 |
| Stage3-vs-Stage4 |
7.355600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62669877568078E-12 |
| Normal-vs-AfricanAmerican |
2.552100E-02 |
| Normal-vs-Asian |
2.633000E-01 |
| Caucasian-vs-AfricanAmerican |
8.0532000000022E-05 |
| Caucasian-vs-Asian |
8.041800E-01 |
| AfricanAmerican-vs-Asian |
5.127600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.30977517299425E-12 |
| Normal-vs-Female |
2.06534789271018E-12 |
| Male-vs-Female |
5.402800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.195900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.61769511517218E-11 |
| Normal-vs-Age(61-80Yrs) |
4.1107117709771E-12 |
| Normal-vs-Age(81-100Yrs) |
1.429870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.309000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.470800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.010200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.352400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.656600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.197200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.261880E-03 |
| Normal-vs-Grade 2 |
4.01999988852708E-10 |
| Normal-vs-Grade 3 |
6.85890000351463E-09 |
| Normal-vs-Grade 4 |
5.49279954853432E-10 |
| Grade 1-vs-Grade 2 |
9.769600E-01 |
| Grade 1-vs-Grade 3 |
9.853200E-01 |
| Grade 1-vs-Grade 4 |
7.203200E-04 |
| Grade 2-vs-Grade 3 |
8.970600E-01 |
| Grade 2-vs-Grade 4 |
2.32269999999035E-05 |
| Grade 3-vs-Grade 4 |
4.06000000000573E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.80020484367105E-11 |
| Normal-vs-ccB subtype |
1.92460047898635E-10 |
| ccA subtype-vs-ccB subtype |
1.275400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.72599753670511E-11 |
| Normal-vs-N1 |
4.375800E-04 |
| N0-vs-N1 |
6.100000E-03 |
|
|
